martes, 7 de abril de 2020

Biotech in the time of coronavirus: Pondering the future of 'JPM Week'

Biotech in the time of coronavirus: Pondering the future of 'JPM Week'

Daily Recap

STAT Plus: Biotech in the time of coronavirus: Pondering the future of ‘JPM Week’

By ADAM FEUERSTEIN


MIKE REDDY/STAT
In this edition: Will #JPM21 be a thing? Also, some straight talk from Alexis Borisy, Daphne Zohar and Abbie Celniker, and another biotech investor survey.

No hay comentarios: